Short answer. The founder thinks so, and parts of the record back him. Legal markets turned flower into a commodity: wholesale prices fell by roughly 75-82 % [9], Oregon flower now sells at its lowest median price since legalisation [7], Washington lost 31.6 % of its producer businesses between 2017 and 2023 [8], and regulators have recalled licensed product for aspergillus, failed microbial limits and banned pesticides [3][4][5]. What the data don't show is that the grey market was cleaner: Health Canada's own tests found illegal flower far dirtier than legal flower [1]. The fault line isn't legal vs illegal. It's craft vs industrial, and the surest craft is your own, grown where it's legal.
Founder's view (house position, round 7). In the founder's opinion, legalisation's commercial model was the worst thing that happened to cannabis quality. Better product and better care existed in the grey-market era and with small mom-and-pop growers, who've since been priced out by large facilities. This is his opinion, from decades of growing. Below is the evidence that supports it, and the evidence that cuts against it. GenetixBay never encourages buying from an illegal market; the answer we push is craft, documentation, and growing your own where your local rules allow it.
The case for the founder's view
1. Flower became a commodity, priced to the floor
| Market | What happened | Source |
|---|---|---|
| California | Wholesale sinsemilla about US$5,500/lb in 2010; spot index about US$1,000/lb in September 2022 (−82 %, inflation-adjusted) | Caulkins 2022 [9] |
| Washington | Wholesale about US$4,085/lb (2006) to about US$950/lb (2022), −77 %; retail bud about US$40/g (2006) to about US$10/g | Caulkins 2022 [9] |
| Washington, first 2.5 legal years | About 45 million priced items in the state's seed-to-sale data: prices fell steadily at both processor and retail level | Caulkins et al. 2018 [10] |
| Oregon | Median retail flower US$3.85/g (2023) and US$3.75/g (2024), "the lowest point the market has seen since legalization", blamed on oversupply. Estimated demand was 57 % of the 2024 harvest | OLCC 2025 [7] |
| Canada | Legal flower averaged about CA$10.23/g in Q3 2019 [18]; prices have fallen since, which is why excise now takes a larger share of each sale (see below) [14][15] | StatCan 2019; Competition Bureau 2023 |
Caulkins, an economist who generally favours tight regulation, puts it bluntly: product differentiation is the "natural strategic response to commoditization" [9]. When a gram sells for a few dollars, the business that survives is the one that grows the most grams for the least money. That is a cost incentive, not a quality incentive.
2. The small farms are the ones leaving
- Washington: producer and producer-processor businesses fell from 973 (2017) to 666 (2023). Producers' five-year survival rate is 44 %, against 71 % for retailers; annual turnover about 11 % [8].
- California: in the first two years of state permits, the largest 10 % of farms held about 60 % of permitted cultivation area statewide. Growth in permitted area shifted towards larger, newer farms on flatter land, away from the small, older farms of the remote northern hills [12].
- California compliance: in a survey of 362 farmers, high cost (permits plus bringing a site up to standard) was the most-cited reason for not licensing. Among farms growing under about 100 lb, only 43 % had applied [11]. The authors describe financial, administrative and psychological barriers that "disproportionately affect farmers with fewer resources" [11].
- California tax: a cultivation tax of US$161.28 per pound of dried flower applied regardless of the farm's selling price until it was repealed on 1 July 2022 [13].being reviewed
- Oregon: low-fee open licensing produced massive oversupply, then a producer licence moratorium (2019), a near-total licence moratorium (2022) and per-capita caps (2024). The regulator expects no new producer licences "for many years" and warns of "additional market consolidation" [7].
3. Canada's tax and compliance load falls hardest on small growers
- Excise duty on dried cannabis is the greater of CA$1 per gram or 10 % of the sale. The Competition Bureau estimated excise affects producers' gross revenue by 30 % or more, and found 66 % of licensees remitting excise owed the Canada Revenue Agency money as of September 2022 [14].being reviewed
- The Bureau called licensing and compliance costs "particularly burdensome for small and medium-sized businesses", with sites needing to be fully built before a licence is issued [14].
- The federal expert panel noted the duty was designed when prices were much higher, asked Finance Canada to review it, and recommended letting micro-cultivators sell direct to distributors [15].
- Micro-licences are now the most common new licence type: of roughly 900 federal licence holders in March 2024, about 396 were micros; 2024 saw 106 revocations against 101 new licences [16].
4. Recalls and contamination in the legal supply
Regulator actions are a matter of public record. We describe them without naming businesses.
- Michigan, November 2021: the state regulator recalled flower, pre-rolls and other products tested by one laboratory over roughly three months, citing "inaccurate and/or unreliable" results after product that had failed for aspergillus was later passed. Reported scale: about 64,000 lb of product [3].
- Colorado, 2015-2017: state and Denver health advisories, holds and recalls for licensed product with residues of pesticides not allowed on cannabis, including myclobutanil, avermectin and imidacloprid [4].being reviewed
- California, 2024: a newspaper investigation had 42 licensed retail products tested privately; 25 showed pesticide levels above state limits or above federal tobacco standards. The state regulator later recalled at least one product it had been told about months earlier [5]. These are private tests, not regulator findings, and an industry review disputed the sample.
- Canada: Health Canada publishes cannabis recalls in its public database; microbial (yeast, mould, bacteria) failures and products not tested for microbes appear regularly, though labelling errors are the most common reason overall [2]. Its random retail sampling has itself triggered a microbial recall [1].
- Potency labels: in Health Canada's sample of 50 legal flower products, 48 % tested under 80 % of their labelled THC [1] (see buyer beware).
5. Irradiation: decontaminate the batch instead of growing it clean
Large facilities can irradiate finished flower to meet microbial limits. In one study, standard gamma irradiation left THC and CBD unchanged but cut some monoterpenes by a typical 10-20 %, and terpinolene by 38 % in one variety [6]. A grower who controls mould in the room has no need for it. The full methods, rules and studies are in irradiated cannabis.
What the evidence doesn't show
This section matters most if you're going to argue the point in public.
- No data show the grey market was cleaner. Nobody systematically tested grey-market flower. The best modern comparison runs the other way: in Health Canada's 2023 survey, 94 % of illegal samples had multiple pesticides (average 3.4, 24 different compounds, myclobutanil and paclobutrazol most common), against trace levels in just 2 of 50 legal samples. Illegal samples also carried more mycotoxins and microbes, including opportunistic pathogens [1]. Today's seized illegal product isn't the same thing as a careful small grower of the 1990s, but it's the only measured comparison we have.
- "Better care" is the founder's experience, not a measurement. We have no controlled tasting or chemistry data comparing grey-market craft with today's industrial flower.
- Concentration isn't uniform. Canada's market is fragmented, not monopolised: the largest producer held "just over 10 %" in 2023 and the top firms' share has fallen since early legalisation [14]. The pressure on small growers there comes mainly from price, tax and compliance cost, not from one giant.
- Many recalls are about testing, not growing. The Michigan recall was triggered by unreliable laboratory results [3]. That's a failure of the industrial testing chain, which supports scepticism about labels, but it doesn't prove the plants were grown carelessly.
- Oregon cuts both ways. It had low fees and many small producers, and still saw prices collapse from oversupply [7]. Cheap licences alone don't save the craft grower.
- Consumers say they like craft more than they pay for it. Surveys find many buyers would pay only a small premium for small-batch flower (the ones we found are commercial polls)being reviewed.
Where craft is fighting back
- Appellations of origin. California is building a Cannabis Appellations Program: producer-led petitions to define place-based standards, with labels enforced by the state's cannabis regulator. Petitions were expected to open in 2026 [17].
- Micro-licences in Canada and smaller tiers elsewhere give a legal route for small-batch growers, though the economics remain hard [14][15][16].
- Home grow, where legal. The only supply chain you fully control is your own: your genetics, your IPM, your dry and cure (see drying and curing), no irradiation, no lab shopping. Check your local rules first; start with the first grow guide.
What GenetixBay does about it
- Document the craft. Every line gets a GB-ID with lineage, grow journals and test results, so quality is something you can show, not a word on a jar.
- Reward care, not volume. On the Bay, yield and potency numbers never earn rewards by themselves; journals, males in the Stud Book, preservation of lost lines and open trials do.
- Settle it with data. Bay Trials can compare small-batch and industrial practices side by side, with blind panels and lab tests, so the next round of this argument has better numbers.
- Keep the gene pool open. See why everything tastes the same and patents and the gene pool.
Evidence
- Wholesale and retail price collapse after legalisation: Supported by regulator data and economic analysis [7][9][18].
- Small producers exiting and area concentrating in larger farms: Supported in Washington and California [8][11][12]; Canada's market is fragmented, with pressure from tax and compliance cost [14][15].
- Excise and compliance burden on small Canadian producers: Supported by the Competition Bureau and the expert panel [14][15].
- Contamination and recalls in legal supply: Supported as documented regulator actions [2][3][4] and one private-testing investigation [5]; rates relative to the old grey market are unknown.
- Irradiation reduces some terpenes: Supported (one controlled study) [6].
- Grey-market or mom-and-pop product was better cared for: founder's view; Contested. The only measured legal-vs-illegal comparison favours legal product on contaminants [1].
Decriminalisation removes or reduces criminal penalties for some cannabis offences; legalisation creates a lawful framework for production, sale and use.The grey market is cannabis supply outside the licensed system where use is legal or tolerated, or in a legal gap; it carries legal risk and no product oversight.Sinsemilla (sensi) is seedless cannabis flower from unpollinated female plants; the word is Spanish for "without seed".A micronutrient is an essential element plants need only in trace amounts, below a few mg/L: iron, manganese, zinc, copper, boron, molybdenum, chlorine and nickel.THC (Δ9-tetrahydrocannabinol) is the neutral, decarboxylated cannabinoid mainly responsible for cannabis's reported intoxicating effects; the living plant makes it almost entirely as THCA.Cannabis irradiation is treating harvested flower with ionising radiation, gamma, electron beam or X-ray, to cut microbial counts; permission and labelling rules vary.CBD (cannabidiol) is a non-intoxicating neutral cannabinoid formed when CBDA decarboxylates; hemp-type and CBD-dominant cannabis make it mainly as CBDA in their trichomes.A monoterpene is a ten-carbon terpene made from geranyl pyrophosphate, such as myrcene, limonene, pinene or terpinolene; they are the most volatile terpenes and the first lost in drying.Mycotoxins are toxic compounds made by certain moulds, such as aflatoxins and ochratoxin A from Aspergillus and Penicillium species; cannabis labs test for them at parts-per-billion levels.Integrated pest management: preventing and controlling pests by combining monitoring, prevention, cultural, biological and, as a last resort, chemical tools against set action thresholds.Lab shopping is the practice of choosing testing labs because they report higher potency or more passing results, rather than because they are most accurate.A GB-ID is GenetixBay's permanent identifier, such as GB-GEN-0001842-6, for a genetic line, landrace, seed batch, plant, cut, grow, harvest, trial or document, so records never get lost or renamed.The Stud Book is GenetixBay's showcase of documented male plants, with selection journals, keeper details and sire credits; males are encouraged and rewarded.Bay Trials are GenetixBay's member-run controlled grow experiments that test growing claims side by side and publish the results openly.The gene pool is the total set of alleles present in a population, cultivar group or species; a narrow gene pool limits what breeders can select from.Terpenes are volatile hydrocarbon compounds built from five-carbon isoprene units; in cannabis they are made in the trichome heads and are a major part of aroma and flavour.
